The Latest Breaking News on Pharma

The biotech industry is well-positioned to witness significant growth due to technological advancements and government spending. Moreover, given the sector’s defensive nature, biotech stocks Amicus Therapeutics (FOLD), Corcept Therapeutics (CORT), and Harmony Biosciences (HRMY) might be solid buys in 2023. Read on.

DCGI calls for bridging bio-tech interface to get out of generic mindset

As a slowdown in monetary policy tightening is paving its way, the possibility of a soft landing still stands. Therefore, it could be an ideal opportunity for investors to load up on some fundamentally sound growth stocks, Novartis (NVS), Daimler Truck Holding (DTRUY), and CPI Aerostructures (CVU). Read on….

Given the breakthrough developments and government initiatives, the biotech industry is well-positioned to grow steadily. Therefore, fundamentally strong biotech stocks Amicus Therapeutics (FOLD) and POINT Biopharma (PNT) could be worth buying now. Read on.

The No7 anti-ageing serum is usually £34.95 and has been reduced to £10 as part of Boots' weekly £10 Tuesday offers

Proposal is designed to free up 15m GP appointments over the next two years

Leading healthcare company McKesson’s (MCK) stock looks undervalued at its current price and could be an excellent pick for value investors. Let’s look at some of MCK’s key metrics.

The Police Association says alternative policy could have been pushed through in order to enable roadside drug testing on time.

Government proposals to improve access to primary care are expected on Tuesday.